One would agree. We may be very close to validation news. As IR explained to me the company is in hopes that ODAC and FDA will push forward validation for MK because of H1N1 validation. IR also told me that a list of patients has been created for the MK trial. This would suggest a patient that signs up for the trial is being told we are close. I beleive thia because patients would not delay conventional treatment without cause..People, we are close to validation. Perhpas even this week.